Cargando…

Development and characterization of polyclonal antibody against human kappa light chain in rabbit

Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in norm...

Descripción completa

Detalles Bibliográficos
Autores principales: Esparvarinha, Mojgan, Nickho, Hamid, Aghebati-Maleki, Leili, Abdolalizadeh, Jalal, Nasiri, Hadi, Valedkarimi, Zahra, Majidi, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Urmia University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828161/
https://www.ncbi.nlm.nih.gov/pubmed/31737229
http://dx.doi.org/10.30466/vrf.2018.81414.2077
_version_ 1783465368728109056
author Esparvarinha, Mojgan
Nickho, Hamid
Aghebati-Maleki, Leili
Abdolalizadeh, Jalal
Nasiri, Hadi
Valedkarimi, Zahra
Majidi, Jafar
author_facet Esparvarinha, Mojgan
Nickho, Hamid
Aghebati-Maleki, Leili
Abdolalizadeh, Jalal
Nasiri, Hadi
Valedkarimi, Zahra
Majidi, Jafar
author_sort Esparvarinha, Mojgan
collection PubMed
description Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in normal condition. The purpose of this study was the production and purification of polyclonal immunoglobulin G (IgG) against human kappa light chains. In this study, early human IgG was purified by ion-exchange chromatography, reduced with Dithiothreitol and heavy and light chains were separated with size-exclusion chromatography. Afterward, affinity chromatography with protein L Sepharose at pH 2.00 was displayed to be a dominant condition for the separation and purification of the kappa light chain of immunoglobulins from human serum. Eventually, the rabbit was immunized by human kappa light chains. The rabbit IgG was purified and labeled with horseradish peroxidase (HRP). Direct enzyme-linked immunosorbent assay was planned to determine the titer of HRP conjugated rabbit IgG against the human kappa light chain. The optimum titer of anti-kappa IgG was 1:16000. At the result, purified polyclonal anti-kappa is useful tool in biomedical and biochemical researches and diagnostic kits.
format Online
Article
Text
id pubmed-6828161
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Urmia University Press
record_format MEDLINE/PubMed
spelling pubmed-68281612019-11-15 Development and characterization of polyclonal antibody against human kappa light chain in rabbit Esparvarinha, Mojgan Nickho, Hamid Aghebati-Maleki, Leili Abdolalizadeh, Jalal Nasiri, Hadi Valedkarimi, Zahra Majidi, Jafar Vet Res Forum Original Article Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in normal condition. The purpose of this study was the production and purification of polyclonal immunoglobulin G (IgG) against human kappa light chains. In this study, early human IgG was purified by ion-exchange chromatography, reduced with Dithiothreitol and heavy and light chains were separated with size-exclusion chromatography. Afterward, affinity chromatography with protein L Sepharose at pH 2.00 was displayed to be a dominant condition for the separation and purification of the kappa light chain of immunoglobulins from human serum. Eventually, the rabbit was immunized by human kappa light chains. The rabbit IgG was purified and labeled with horseradish peroxidase (HRP). Direct enzyme-linked immunosorbent assay was planned to determine the titer of HRP conjugated rabbit IgG against the human kappa light chain. The optimum titer of anti-kappa IgG was 1:16000. At the result, purified polyclonal anti-kappa is useful tool in biomedical and biochemical researches and diagnostic kits. Urmia University Press 2019 2019-09-15 /pmc/articles/PMC6828161/ /pubmed/31737229 http://dx.doi.org/10.30466/vrf.2018.81414.2077 Text en © 2019 Urmia University. All rights reserved This is an open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License, (https://creativecommons.org/licenses/by-nc/4.0/) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Esparvarinha, Mojgan
Nickho, Hamid
Aghebati-Maleki, Leili
Abdolalizadeh, Jalal
Nasiri, Hadi
Valedkarimi, Zahra
Majidi, Jafar
Development and characterization of polyclonal antibody against human kappa light chain in rabbit
title Development and characterization of polyclonal antibody against human kappa light chain in rabbit
title_full Development and characterization of polyclonal antibody against human kappa light chain in rabbit
title_fullStr Development and characterization of polyclonal antibody against human kappa light chain in rabbit
title_full_unstemmed Development and characterization of polyclonal antibody against human kappa light chain in rabbit
title_short Development and characterization of polyclonal antibody against human kappa light chain in rabbit
title_sort development and characterization of polyclonal antibody against human kappa light chain in rabbit
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828161/
https://www.ncbi.nlm.nih.gov/pubmed/31737229
http://dx.doi.org/10.30466/vrf.2018.81414.2077
work_keys_str_mv AT esparvarinhamojgan developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit
AT nickhohamid developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit
AT aghebatimalekileili developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit
AT abdolalizadehjalal developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit
AT nasirihadi developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit
AT valedkarimizahra developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit
AT majidijafar developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit